Axcella Health Financials

Axcella Health Stock Summary

Axcella Health competes with Cyclerion Therapeutics, Kezar Life, CytomX Therapeutics, Assembly Biosciences, and Instil Bio. Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Axcella Health Key Financial Ratios

Axcella Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Axcella Health's current stock value. Our valuation model uses many indicators to compare Axcella Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axcella Health competition to find correlations between indicators driving Axcella Health's intrinsic value. More Info.Axcella Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axcella Health's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

If you are still planning to invest in Axcella Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axcella Health's history and understand the potential risks before investing.